Zheng X L, Mokashi S, Hollenberg M D
Department of Pharmacology and Therapeutics, The University of Calgary, Faculty of Medicine, Alberta, Canada.
J Pharmacol Exp Ther. 1997 Jul;282(1):485-95.
We observed a contractile action of ethanol (20-500 mM) and other alcohols (methanol and propanol, but not butanol) in guinea pig gastric longitudinal (LM) and circular (CM) smooth muscle preparations. The potency order for the alcohols in the LM preparation was: ethanol = propanol > methanol; and in the CM preparation, propanol > ethanol > methanol. Like epidermal growth factor-urogastrone (EGF), the contractile actions of ethanol in the LM and CM preparations required extracellular calcium and were blocked by the tyrosine kinase inhibitors, genistein and tyrphostin-47 (AG213). The tyrosine phosphatase inhibitor, pervanadate, potentiated the contractile action of ethanol in the LM preparation. Ethanol-induced contractions in both preparations were not affected by 4-methyl pyrazole, an inhibitor of alcohol dehydrogenase, and were unaffected by tetrodotoxin, atropine, prazosine or yohimbine. In the LM preparation, like EGF, the contractile action of ethanol was blocked by the cyclooxygenase inhibitor, indomethacin, and the diacylglycerol lipase inhibitor, U57,908; in the CM preparation, contractions caused by ethanol and EGF were still observed in the presence of these two inhibitors. Contractions caused by ethanol and EGF in the LM preparation were not affected by the epoxygenase inhibitor, ketoconazole; the lipoxygenase inhibitor, nordihydroguaiaretic acid; or the phospholipase A2 inhibitor, mepacrine. In contrast, in the LM preparation, EGF-induced contractions were attentuated by the EGF receptor-kinase inhibitor, PD153035; the MAP-kinase-kinase (MEK) inhibitor, PD98059; the kinase C inhibitor, GF109203X; and the phosphatidylinositol 3'-kinase inhibitors, Wortmannin and LY294002; whereas ethanol-induced contractions were unaffected by these inhibitors. Both ethanol and EGF caused small increases in the phosphotyrosyl protein content of the gastric tissue. We conclude that ethanol causes its contractile effects in the distinct gastric LM and CM preparations independent of nerve-released agonists and via a tyrosine kinase inhibitor-sensitive signal pathway that is in many respects similar to, but distinct from the one activated by EGF.
我们观察到乙醇(20 - 500 mM)以及其他醇类(甲醇和丙醇,但不包括丁醇)对豚鼠胃纵行肌(LM)和环行肌(CM)平滑肌制剂有收缩作用。在LM制剂中,醇类的效力顺序为:乙醇 = 丙醇 > 甲醇;在CM制剂中,效力顺序为:丙醇 > 乙醇 > 甲醇。与表皮生长因子 - 尿抑胃素(EGF)类似,乙醇在LM和CM制剂中的收缩作用需要细胞外钙,并且被酪氨酸激酶抑制剂染料木黄酮和 tyrphostin - 47(AG213)所阻断。酪氨酸磷酸酶抑制剂过氧钒酸盐增强了乙醇在LM制剂中的收缩作用。乙醇在两种制剂中诱导的收缩不受醇脱氢酶抑制剂4 - 甲基吡唑的影响,也不受河豚毒素、阿托品、哌唑嗪或育亨宾的影响。在LM制剂中,与EGF类似,乙醇的收缩作用被环氧合酶抑制剂吲哚美辛和二酰甘油脂肪酶抑制剂U57,908所阻断;在CM制剂中,在这两种抑制剂存在的情况下,仍可观察到乙醇和EGF引起的收缩。乙醇和EGF在LM制剂中引起的收缩不受环氧酶抑制剂酮康唑、脂氧合酶抑制剂去甲二氢愈创木酸或磷脂酶A2抑制剂米帕林的影响。相反,在LM制剂中,EGF诱导的收缩被EGF受体激酶抑制剂PD153035、丝裂原活化蛋白激酶激酶(MEK)抑制剂PD98059、蛋白激酶C抑制剂GF109203X以及磷脂酰肌醇3'-激酶抑制剂渥曼青霉素和LY294002减弱;而乙醇诱导的收缩不受这些抑制剂的影响。乙醇和EGF都使胃组织中磷酸化酪氨酸蛋白含量略有增加。我们得出结论,乙醇在不同的胃LM和CM制剂中产生收缩作用,独立于神经释放的激动剂,并且通过一条对酪氨酸激酶抑制剂敏感的信号通路,该通路在许多方面与EGF激活的通路相似,但又有所不同。